Israel Englander’s Dimension Therapeutics, Inc DMTX Stock Holding History

Israel Englander’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-136,548	Closed	-$819K	–	4347
2017 Q3	$819K	Sell	136,548 -136,151	-50%	-$353K	﹤0.01%	2622
2017 Q2	$395K	Buy	272,699 +84,805	+45%	+$115K	﹤0.01%	2921
2017 Q1	$329K	Buy	187,894 +12,802	+7%	+$34K	﹤0.01%	3006
2016 Q4	$762K	Buy	+175,092	New	+$932K	﹤0.01%	2408

Israel Englander's DMTX Position: Q4 2017 in Review

Israel Englander sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 136,548 shares — an estimated $819K sold.

Israel Englander first reported a position in DMTX in Q4 2016 and held it in 4 quarters. The position peaked at $819K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Israel Englander reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Israel Englander sold 136,548 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $819K.
Israel Englander first reported a position in Dimension Therapeutics, Inc in Q4 2016 and held it in 4 quarters.
Israel Englander's Dimension Therapeutics, Inc position peaked at $819K in Q3 2017.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.